Cervical Fusion

Fusion rates of 97.6% at 12 months and 100% at 18 months when OSTEOAMP was used, exceed fusion rates reported in the literature for traditional DBMs.3
OSTEOAMP has been shown to retain up to 23 natural growth factors that support bone formation.1
See clinical dataOSTEOAMP granules combine osteoconductive and osteoinductive properties with mineralized cortical-cancellous allograft chips.
All formats may be rehydrated with bone marrow aspirate, blood, or saline. For optimal handling of the putty, bone marrow aspirate or blood are recommended.
Combines both osteoconductive and osteoinductive properties in an easy-to-use compressible sponge. The malleable implant readily conforms to various interbody devices and/or bony defects.
Fusion rates of 97.6% at 12 months and 100% at 18 months when OSTEOAMP was used, exceed fusion rates reported in the literature for traditional DBMs.3
A higher percentage of patients achieved fusion in the OSTEOAMP group at all time points than the in the rhBPM-2 group (p<0.01). Total time for fusion for OSTEOAMP was approximately 40% shorter than that of rhBPM-2 (207.9 and 333.9 days, respectively).2
To request more information on OSTEOAMP or to contact your local Bioventus Surgical representative to order, please fill out this form.
Instructions For Use
OSTEOAMP – DCI Doner Services Tissue Bank
OSTEOAMP – Lifelink Tissue Bank
OSTEOAMP – Pinnacle Transplant Technologies
Material Management Packet
OSTEOAMP – Material Management Packet